Ken Griffin Tilray Brands, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.62 - $2.03 $1.28 Million - $1.6 Million	789,100 Added 106.05%	1,533,200 $2.68 Million
Q2 2024 Aug 14, 2024	SELL	$1.62 - $2.85 $734,994 - $1.29 Million	-453,700 Reduced 37.88%	744,100 $1.24 Million
Q1 2024 May 15, 2024	BUY	$1.6 - $2.48 $373,280 - $578,584	233,300 Added 24.19%	1,197,800 $2.96 Million
Q4 2023 Feb 14, 2024	SELL	$1.66 - $2.41 $795,618 - $1.16 Million	-479,288 Reduced 33.2%	964,500 $2.22 Million
Q3 2023 Nov 14, 2023	BUY	$1.55 - $3.31 $607,669 - $1.3 Million	392,045 Added 37.28%	1,443,788 $3.45 Million
Q2 2023 Aug 14, 2023	SELL	$1.52 - $2.78 $389,510 - $712,394	-256,257 Reduced 19.59%	1,051,743 $1.64 Million
Q1 2023 May 15, 2023	SELL	$2.36 - $3.35 $1.32 Million - $1.87 Million	-558,274 Reduced 29.91%	1,308,000 $3.31 Million
Q4 2022 Feb 14, 2023	SELL	$2.58 - $4.68 $1.55 Million - $2.82 Million	-601,885 Reduced 24.39%	1,866,274 $5.02 Million
Q3 2022 Nov 14, 2022	BUY	$2.7 - $4.3 $93,690 - $149,210	34,700 Added 1.43%	2,468,159 $6.79 Million

403

99.9M

8.59M

8.9M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $844M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.